COGN-201

N/A

Report date: 2024/11/21 12:00:51
NME

Base Information

Drug NameCOGN-201
Drug Alias NameCOGN-201
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsCognition DisordersAnxiety DisordersMemory Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognigenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCognigenics Inc
Inactive CompaniesN/A
Active IndicationsCognition DisordersAnxiety DisordersMemory Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A